Physicians and researchers from the Children’s National Hospital Division of Gastroenterology, Hepatology and Nutrition presented recent clinical findings at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting in San Diego.
The presentations focused on advancements in pediatric inflammatory bowel disease, AI diagnostic accuracy, and complex hepatology cases.
Clinical Insights for Pediatric Care
- AI Integration: Specialized medical AI models are being compared against general-purpose systems to determine their diagnostic accuracy in pediatric gastroenterology, specifically regarding abdominal imaging and board examination performance.
- Treatment Protocols: New data examines the safety of temporarily pausing biologic therapies—medications that target specific immune system proteins—to allow for necessary live vaccinations in patients with Very Early-Onset Inflammatory Bowel Disease (VEO-IBD).
- Health Disparities: Researchers identified significant variations in surgical outcomes and therapy adherence for Crohn’s disease that correlate with race, ethnicity, and insurance status, highlighting a need for more equitable care delivery.
Advancing Diagnostic Precision with Artificial Intelligence
Vahe Badalyan, MD, and Akif Shameem, MD, led investigations into the efficacy of large language models (LLMs) and specialized AI in a clinical setting. Their work compared general-purpose AI models against specialized medical counterparts using pediatric gastroenterology board questions.
By analyzing the diagnostic output from image-based inputs, the team sought to establish whether these tools can reliably assist in interpreting complex pediatric abdominal imaging. This research addresses the growing need for validated, clinically specific AI tools that can safely support, rather than replace, pediatric gastroenterology specialists.
Managing Complex Inflammatory Bowel Disease
The conference highlighted critical management strategies for children with refractory Crohn’s disease. Najima Mwase, MD, and Diana Moya, MD, presented findings on the development of renal cell carcinoma in patients receiving biologic therapy, showing why long-term surveillance is necessary.
Sam Gulino, MD, and colleagues reported on the use of targeted interferon-gamma (IFN-Γ) blockade for pediatric activated CD8+ T-cell hepatitis. This mechanism of action—specifically inhibiting the protein responsible for inflammatory signaling—represents a targeted approach to managing severe immune-mediated liver injury.
Clinical Findings on Herbal Liver Injury and Multi-Site Lymphoma
Clinical teams presented rare cases to improve diagnostic staging and treatment accuracy for complex pediatric conditions. Gulino, Mwase, Nada Yazigi, MD, and Sloane Zimmerman, MD, detailed a case of ashwagandha-induced liver injury resulting in granulomatous hepatitis.
This finding serves as a clinical reminder to screen for herbal supplement use during patient intake. Anisha Gopu-Gilboy, MD, and her team documented a rare instance of concurrent extranodal marginal zone lymphoma in the ocular adnexa and stomach, showing the diagnostic challenges of multi-site pediatric lymphoma.
| Clinical Focus | Key Research Area | Primary Outcome |
|---|---|---|
| Pediatric Crohn’s Disease | Surgical/Therapeutic Outcomes | Identified racial and insurance-based disparities in ileocecectomy management. |
| Eosinophilic Esophagitis | Treatment Initiation | Developed a fast-track protocol to accelerate patient follow-up and relief. |
| AI Diagnostics | Imaging & Board Accuracy | Compared general vs. specialized model accuracy in pediatric abdominal analysis. |
Contraindications & When to Consult a Doctor
Patients and caregivers should be aware that biologic therapies, such as those used for VEO-IBD, carry specific contraindications, including active systemic infections. The temporary interruption of these therapies for vaccinations must only occur under the strict supervision of a pediatric gastroenterologist, as premature cessation can lead to disease flares.
Families should seek immediate medical intervention if a child experiences persistent abdominal pain, unexplained jaundice, or sudden changes in bowel habits, as these may indicate underlying inflammatory or neoplastic processes requiring diagnostic imaging or endoscopic evaluation.
The findings presented in San Diego emphasize the importance of longitudinal data in pediatric gastroenterology. As the division continues to integrate AI diagnostic support and targeted immune-modulating therapies, the focus remains on mitigating disparities in patient outcomes. Ongoing research into the long-term safety of advanced therapies, particularly for children with complex, refractory disease, remains the primary objective for the coming year.
